There are 2789 resources available
1479P - Exploring second-line therapy outcome in pancreatic ductal adenocarcinoma (PDAC) patients with germlineBRCA1-2 pathogenic variants (gBRCA1-2pv)
Presenter: Giulia Orsi
Session: ePoster Display
1480P - Real-world progression outcomes among patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC) treated with liposomal irinotecan-based regimens in the United States
Presenter: George Kim
Session: ePoster Display
1481P - Predictors for 30-day readmission in patients with pancreatic cancer who had DNR code status
Presenter: Jasmeet Kaur
Session: ePoster Display
1482P - Landscape of germline pathogenic variants beyond BRCA in pancreatic cancer patients
Presenter: Roberto Borea
Session: ePoster Display
1483P - Cell-free DNA dominant clone allele frequency associates with poor outcomes in advanced pancreatic cancer
Presenter: Pedro Uson Junior
Session: ePoster Display
1484P - Impact of time to diagnostic imaging on survival of patients with pancreatic cancer
Presenter: Vittoria Balzano
Session: ePoster Display
1485P - Identification of novel protein biomarkers for FOLFIRINOX-based chemotherapy response in advanced pancreatic adenocarcinoma using patient omics and Bayesian AI
Presenter: A. Moser
Session: ePoster Display
1486P - Clinicopathological characteristics and prognostic factors of ampullary cancer: A tertiary care centre experience over 10 years
Presenter: Aditya Singla
Session: ePoster Display
1487TiP - A randomized non-comparative phase II study of maintenance therapy with FOLFIRI alone or in combination with Tedopi vaccine after induction therapy with FOLFIRINOX in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma (TEDOPAM – D17-01 PRODIGE 63 STUDY)
Presenter: Marc Hilmi
Session: ePoster Display
1489P_PR - Tunisian children and adolescents coping with parental cancer
Presenter: Sinen Korbi
Session: ePoster Display